BioCentury
ARTICLE | Clinical News

Epix Medical reports preliminary MRI data

March 20, 2000 8:00 AM UTC

EPIX reported preliminary Phase II data in 20 patients showing signal enhancement and prolonged imaging time using its AngioMark MRI contrast agent for breast cancer imaging after intravenous injectio...